<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03228004</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201700818</org_study_id>
    <nct_id>NCT03228004</nct_id>
  </id_info>
  <brief_title>Type 1 Diabetes Data Acquisition and Transfer Adherence Study</brief_title>
  <acronym>T1D-DATA</acronym>
  <official_title>Type 1 Diabetes Data Acquisition and Transfer Adherence Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to determine if training and support, combined with&#xD;
      reminders to facilitate glucose data sharing with the diabetes care team in between clinic&#xD;
      visits, can improve glycemic outcomes for patients ages 10-17 with type 1 diabetes who have&#xD;
      HbA1c levels above target.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 26, 2017</start_date>
  <completion_date type="Actual">April 8, 2019</completion_date>
  <primary_completion_date type="Actual">April 24, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improved glycemic control</measure>
    <time_frame>16 weeks</time_frame>
    <description>HbA1c</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of data upload</measure>
    <time_frame>16 weeks</time_frame>
    <description>The number of times glucose data is uploaded between clinic visits</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be provided with training on how to upload glucose data via GLOOKO and will receive reminders to upload glucose data on a biweekly basis between clinic visits.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Glooko MeterSync</intervention_name>
    <description>The participant and caregiver will receive a reminder via text or email to upload glucose data via Glooko on a biweekly basis.</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis with T1D at least 6 months before consent is obtained&#xD;
&#xD;
          -  Aged ≥ 2 years and ≤17 years at time of enrollment&#xD;
&#xD;
          -  Must have access to a smartphone, tablet or computer at home with wireless&#xD;
             connectivity&#xD;
&#xD;
          -  Last HbA1c of ≥7.6% and ≤11%&#xD;
&#xD;
          -  Using fixed doses, multiple daily injections or an insulin pump as primary diabetes&#xD;
             management regimen&#xD;
&#xD;
          -  Ability to read and speak English&#xD;
&#xD;
          -  Patient at UF Health Pediatric Diabetes Clinic&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant medical comorbidity in the child or adolescent that could, in the opinion&#xD;
             of the PI, affect participant's capacity to complete study follow up&#xD;
&#xD;
          -  Inability to read and speak English&#xD;
&#xD;
          -  Not using insulin therapy&#xD;
&#xD;
          -  Lack of access to mobile device or computer with wireless internet connectivity&#xD;
&#xD;
          -  Unwilling or unable to use clinic's software (Glooko) to facilitate glucose data&#xD;
             upload&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anastasia Albanese-O'Neill, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>July 21, 2017</study_first_submitted>
  <study_first_submitted_qc>July 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2017</study_first_posted>
  <last_update_submitted>April 10, 2019</last_update_submitted>
  <last_update_submitted_qc>April 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

